Venture Partner

Chika Yoshinaga, MD, is VP Asia, M.D., M.S. She joined Sofinnova Partners in 2007.  Over her four years as Deputy General Manager at NIF SMBC Ventures, Chika invested in five life sciences companies, four based in Europe and one in the United States. Three have completed initial public offerings: Acorda Therapeutics (NASDAQ: ACOR), BioXell (SWX: BXLN), and Innate Pharma (EURONEXT: IPH). Prior to joining the venture capital industry, Chika worked as a System Engineer in the Information System Division of the Health and Science Research Institute in Yokohama, Japan. She was also a physician intern and practiced medicine at WuaTong Hospital in Shanghai, China. Chika earned an M.S. in Bio-Engineering from Yokohama National University in Japan, as well as an M.D. in Clinical Medicine from Shanghai Medical University in China.